Hb. Kaltreider et al., UP-REGULATION OF NEUROPEPTIDES AND NEUROPEPTIDE RECEPTORS IN A MURINEMODEL OF IMMUNE INFLAMMATION IN LUNG PARENCHYMA, American journal of respiratory cell and molecular biology, 16(2), 1997, pp. 133-144
The lung is richly supplied with peptidergic nerves that store and sec
rete substance P (SP), vasoactive intestinal peptide (VIP), and other
neuropeptides known to potently modulate leukocyte function in vitro a
nd airway inflammation in vivo. To investigate and characterize neurom
odulation of immune responses compartmentalized in lung parenchyma, ne
uropeptide release and expression of neuropeptide receptors were studi
ed in lungs of antigen-primed C57BL/6 mice after intratracheal challen
ge with sheep erythrocytes. The concentrations of cytokines in broncho
alveolar lavage (BAL) fluid rose early and peaked on day 1 for interle
ukin (IL)-2, interferon gamma, and IL-10; days 1 to 2 for IL-6; and da
y 3 for IL-4, whereas the total number and different types of leukocyt
es in BAL fluid peaked subsequently on days 4 to 6 after i.t. antigen
challenge. Immunoreactive SP and VIP in BAL fluid increased maximally
to nanomolar concentrations on days 1 to 3 and 2 to 7, respectively in
lungs undergoing immune responses. The high-affinity SP receptor (NK-
1 R), and VIP types I (VIPR1) and II (VIPR2) receptors were localized
by immunohistochemistry to surface membranes of mononuclear leukocytes
and granulocytes in perivascular, peribronchiolar, and alveolar infla
mmatory infiltrates during immune responses. As quantified by reverse
transcription-polymerase chain reaction, significant increases were ob
served in levels of BAL lymphocyte mRNA encoding NK-1 R (days 2 to 4),
VIPR1 (days 2 to 4), and VIPR2 (days 4 to 6), and in alveolar macroph
age mRNA encoding NK-1 R (days 2 to 6) and VIPR1 (days 2 to 4), but no
t VIPR2. Systemic treatment of mice with a selective, nonpeptide NK-1
R antagonist reduced significantly the total numbers of leukocytes, ly
mphocytes, and granulocytes retrieved by BAL on day 5 of the pulmonary
immune response. The results indicate that SP and VIP are secreted lo
cally during pulmonary immune responses, and are recognized by leukocy
tes infiltrating lung tissue, and thus their interaction may regulate
the recruitment and functions of immune cells in lung parenchyma.